Tranexamic acid adverse reactions: a brief summary for internists and emergency doctors

Tranexamic acid (TXA) is a synthetic lysine analogue that is well known as antifibrinolytic agent. It can reduce blood loss in clinical use, especially in conditions where fibrinolysis or hyperfibrinolysis are involved, such as trauma or surgery. Moreover, TXA has been approved as second-line prophy...

Descripción completa

Detalles Bibliográficos
Autores principales: Murdaca, Giuseppe, Greco, Monica, Vassallo, Chiara, Gangemi, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473809/
https://www.ncbi.nlm.nih.gov/pubmed/32908455
http://dx.doi.org/10.1186/s12948-020-00131-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473809/
https://www.ncbi.nlm.nih.gov/pubmed/32908455
http://dx.doi.org/10.1186/s12948-020-00131-8

Ejemplares similares